Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

Cowen & Co. Maintains Outperform on Danaher, Lowers Price Target to $320

By Benzinga Newsdesk

January 25, 9:12 AM

Cowen & Co. analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Outperform and lowers the price target from $340 to $320.

DHR

Earnings

Recap: RCM Technologies Q1 Earnings

By Benzinga Insights

May 9, 5:00 PM

RCM Technologies (NASDAQ:RCMT) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM. Here’s what…

RCMT

News

Schwab Announces Enhancements To Trading Experience On Schwab.com And Schwab Mobile

By Happy Mohamed

May 10, 8:38 AM

New tools and features including SnapTicket® and streaming market data make trading experience more intuitive and streamlined Charles Schwab today announced several new enhancements to the trading experience on

SCHW

YETI Holdings Beat Q2 Estimates Despite Lower Sales, Raises 2023 Earnings Outlook; Shares Surge Higher

By Nabaparna Bhattacharya

August 10, 10:08 AM

YETI Holdings, Inc. (NYSE: YETI) second-quarter 2023 sales fell 4% Y/Y to $402.56 million,

YETI

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Related Posts

Cowen & Co. Maintains Outperform on Danaher, Lowers Price Target to $320

Recap: RCM Technologies Q1 Earnings

Schwab Announces Enhancements To Trading Experience On Schwab.com And Schwab Mobile

YETI Holdings Beat Q2 Estimates Despite Lower Sales, Raises 2023 Earnings Outlook; Shares Surge Higher